New therapies possible after finding immune cell changes in lymphoplasmacytic lymphoma
In competition with a humanoid robot, humans delay their decisions when the robot looks at them
1 September 2021Mathematical model reveals possible role of drug-eluting stents in artery re-closure
1 September 2021New therapies possible after finding immune cell changes in lymphoplasmacytic lymphoma
A new study by researchers at Winship Cancer Institute of Emory University finds that cancer-associated mutations originate in blood progenitor cells, leading to distinct changes in both cancer and non-cancer immune cells in Waldenstrom macroglobulinemia (WM), a type of non-Hodgkin lymphoma, and its precursor IgM monoclonal gammopathy of undetermined significance (MGUS).
